Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for modulation of inflammatory mediators in apical periodontitis
IRCT20191211045702N1Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aspirin in apical periodontitis (AP) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoints: Lipoxin A4 concentration in periapical exudate, Interleukin-1 beta concentration in periapical exudate and 1 more. Started Jan 2020; status: completed.
02
Drugs
aspirin
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on IRCT20191211045702N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191211045702N1.